Alendronic acid: synovitis, myalgia and arthralgia.
D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D018771:Arthralgia / Q000139:chemically induced*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009140:Musculoskeletal Diseases / Q000139:chemically induced*; D009520:New Zealand; D013585:Synovitis / Q000139:chemically induced*
D004164:Diphosphonates; D019386:Alendronate